Why Teva Pharmaceutical Stock Is Soaring Today
Werte in diesem Artikel
Shares of Teva Pharmaceutical (NYSE: TEVA) are surging on Wednesday. The company's stock is up 9.2% as of 1:15 p.m. ET and was up as much as 9.5% earlier in the day. The leg up comes as the S&P 500 is up 0.4% and the Nasdaq Composite is losing 0.1% on the day so far.The Israel-based pharmaceutical company reported strong Q1 earnings today and raised its full-year profit guidance.Teva reported Q1 adjusted earnings per share (EPS) of $0.52, solidly beating Wall Street's target of $0.48. The company missed on sales, however, reporting $3.89 billion for the quarter when $4 billion was expected. Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Übrigens: Teva Pharmaceutical Industries und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Teva Pharmaceutical Industries
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Teva Pharmaceutical Industries
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: MotleyFool
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)
Analysen zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Teva Pharmaceutical Industries Peer Perform | Wolfe Research | |
11.06.2019 | Teva Pharmaceutical Industries Underweight | Barclays Capital | |
03.06.2019 | Teva Pharmaceutical Industries Outperform | Oppenheimer & Co. Inc. | |
29.03.2019 | Teva Pharmaceutical Industries Market Perform | BMO Capital Markets | |
21.09.2018 | Teva Pharmaceutical Industries Perform | Oppenheimer & Co. Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
03.06.2019 | Teva Pharmaceutical Industries Outperform | Oppenheimer & Co. Inc. | |
29.03.2019 | Teva Pharmaceutical Industries Market Perform | BMO Capital Markets | |
09.01.2018 | Teva Pharmaceutical Industries Buy | Mizuho | |
11.09.2017 | Teva Pharmaceutical Industries Buy | BTIG Research | |
17.07.2017 | Teva Pharmaceutical Industries Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Teva Pharmaceutical Industries Peer Perform | Wolfe Research | |
21.09.2018 | Teva Pharmaceutical Industries Perform | Oppenheimer & Co. Inc. | |
17.09.2018 | Teva Pharmaceutical Industries Neutral | BTIG Research | |
09.02.2018 | Teva Pharmaceutical Industries Hold | Gabelli & Co | |
09.02.2018 | Teva Pharmaceutical Industries Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
11.06.2019 | Teva Pharmaceutical Industries Underweight | Barclays Capital | |
02.02.2018 | Teva Pharmaceutical Industries Sell | BTIG Research | |
03.11.2017 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
30.10.2017 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
18.09.2017 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teva Pharmaceutical Industries Ltd. (spons. ADRs) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen